全文获取类型
收费全文 | 2182篇 |
免费 | 64篇 |
国内免费 | 3篇 |
专业分类
电工技术 | 17篇 |
综合类 | 3篇 |
化学工业 | 289篇 |
金属工艺 | 27篇 |
机械仪表 | 65篇 |
建筑科学 | 39篇 |
矿业工程 | 1篇 |
能源动力 | 51篇 |
轻工业 | 88篇 |
水利工程 | 13篇 |
石油天然气 | 2篇 |
无线电 | 264篇 |
一般工业技术 | 213篇 |
冶金工业 | 939篇 |
原子能技术 | 7篇 |
自动化技术 | 231篇 |
出版年
2023年 | 32篇 |
2022年 | 44篇 |
2021年 | 74篇 |
2020年 | 62篇 |
2019年 | 56篇 |
2018年 | 69篇 |
2017年 | 41篇 |
2016年 | 84篇 |
2015年 | 29篇 |
2014年 | 59篇 |
2013年 | 77篇 |
2012年 | 64篇 |
2011年 | 52篇 |
2010年 | 61篇 |
2009年 | 49篇 |
2008年 | 42篇 |
2007年 | 51篇 |
2006年 | 41篇 |
2005年 | 27篇 |
2004年 | 32篇 |
2003年 | 29篇 |
2002年 | 25篇 |
2001年 | 20篇 |
2000年 | 17篇 |
1999年 | 63篇 |
1998年 | 325篇 |
1997年 | 184篇 |
1996年 | 113篇 |
1995年 | 67篇 |
1994年 | 63篇 |
1993年 | 74篇 |
1992年 | 24篇 |
1991年 | 17篇 |
1990年 | 15篇 |
1989年 | 14篇 |
1988年 | 13篇 |
1987年 | 7篇 |
1986年 | 12篇 |
1985年 | 11篇 |
1984年 | 6篇 |
1983年 | 2篇 |
1982年 | 9篇 |
1981年 | 2篇 |
1980年 | 11篇 |
1978年 | 3篇 |
1977年 | 23篇 |
1976年 | 45篇 |
1975年 | 3篇 |
1968年 | 1篇 |
1960年 | 1篇 |
排序方式: 共有2249条查询结果,搜索用时 78 毫秒
191.
BACKGROUND: Before the routine use of recombinant human erythropoietin (rHuEpo), patients dialysed by peritoneal dialysis (PD) received fewer blood transfusions than patients on haemodialysis (HD). We compared transfusion practices in these groups now that the use of rHuEpo has become standard, while controlling for variables known to influence anaemia of end-stage renal disease (ESRD). Maintenance rHuEpo doses were also compared. METHODS: Data were examined for 157 HD and 126 PD patients during a 2-year period. Potential confounders included age, gender, albumin, iron deficiency, parathyroid hormone (PTH), underlying renal disease, comorbid illness, renal transplant, dialysis adequacy and duration. An intent-to-treat analysis was used, with sensitivity analyses to account for change in treatment and transplant. RESULTS: Mean haemoglobin (Hb) was not different (10.47 g/dl for HD, 10.71 g/dl for PD; P = 0.45). Mean monthly transfusion rate was higher for HD (0.47 units per month vs 0.19; P < 0.01). More HD patients received at least one transfusion (52.9 vs 40.9%; P < 0.01). The maintenance rHuEpo dose was higher for HD (7370 U/week vs 5790 U/week; P = 0.01). The only factors associated with risk of being transfused were dialysis duration and mode of dialysis (less risk for PD, odds-ratio 0.57; 95% confidence interval 0.35-0.92). CONCLUSIONS: Despite the routine use of rHuEpo, HD patients received more blood and rHuEpo than PD patients to achieve the same Hb. No patient factors were identified to account for this difference. The use of fewer transfusions and less rHuEpo in PD represents an advantage over HD in terms of both cost and safety. 相似文献
192.
EW Steyerberg HJ Keizer SD Foss? DT Sleijfer GC Toner H Schraffordt Koops PF Mulders JE Messemer K Ney JP Donohue 《Canadian Metallurgical Quarterly》1995,13(5):1177-1187
PURPOSE: To develop a statistical model that predicts the histology (necrosis, mature teratoma, or cancer) after chemotherapy for metastatic nonseminomatous germ cell tumor (NSGCT). PATIENTS AND METHODS: An international data set was collected comprising individual patient data from six study groups. Logistic regression analysis was used to estimate the probability of necrosis and the ratio of cancer and mature teratoma. RESULTS: Of 556 patients, 250 (45%) had necrosis at resection, 236 (42%) had mature teratoma, and 70 (13%) had cancer. Predictors of necrosis were the absence of teratoma elements in the primary tumor, prechemotherapy normal alfa-fetoprotein (AFP), normal human chorionic gonadotropin (HCG), and elevated lactate dehydrogenase (LDH) levels, a small prechemotherapy or postchemotherapy mass, and a large shrinkage of the mass during chemotherapy. Multivariate combination of predictors yielded reliable models (goodness-of-fit tests, P > .20), which discriminated necrosis well from other histologies (area under the receiver operating characteristic (ROC) curve, .84), but which discriminated cancer only reasonably from mature teratoma (area, .66). Internal and external validation confirmed these findings. CONCLUSION: The validated models estimate with high accuracy the histology at resection, especially necrosis, based on well-known and readily available predictors. The predicted probabilities may help to choose between immediate resection of a residual mass or follow-up, taking into account the expected benefits and risks of resection, feasibility of frequent follow-up, the financial costs, and the patient's individual preferences. 相似文献
193.
Q Li W Wang KB Berst A Claiborne L Hasvold K Raye M Tufano A Nilius LL Shen R Flamm J Alder K Marsh D Crowell DT Chu JJ Plattner 《Canadian Metallurgical Quarterly》1998,8(15):1953-1958
The 8-position side chain of 2-pyridones is believed to be involved in the binding with bacterial DNA gyrase to form the ternary complex, making them very important for the activity of 2-pyridones. A series of 2-pyridones having fluoro-substituted amines at the 8-position has been synthesized and their antibacterial activities and parmacokinetic properties are reported. 相似文献
194.
H Kino H Inaba N Van De L Van Chau DT Son HT Hao ND Toan LD Cong M Sano 《Canadian Metallurgical Quarterly》1998,29(2):250-254
We present the spatial structure of binase, a small extracellular ribonuclease, derived from 1H-NMR* data in aqueous solution. The total of 20 structures were obtained via torsion angle dynamics using DYANA program with experimental NOE and hydrogen bond distance constraints and phi and chi1 dihedral angle constraints. The final structures were energy minimised with ECEPP/2 potential in FANTOM program. Binase consists of three alpha-helices in N-terminal part (residues 6-16, 26-32 and 41-44), five-stranded antiparallel beta-sheet in C-terminal part (residues 51-55, 70-75, 86-90, 94-99 and 104-108) and two-stranded parallel beta-sheet (residues 22-24 and 49-51). Three loops (residues 36-39, 56-67 and 76-83), which play significant role in biological functioning of binase, are flexible in solution. The differences between binase and barnase spatial structures in solution explain the differences in thermostability of binase, barnase and their hybrids. 相似文献
195.
DT Chua JS Sham D Choy V Lorvidhaya Y Sumitsawan S Thongprasert V Vootiprux A Cheirsilpa T Azhar AH Reksodiputro 《Canadian Metallurgical Quarterly》1998,83(11):2270-2283
BACKGROUND: The aim of this trial was to compare the outcome achieved with neoadjuvant chemotherapy followed by radiotherapy to that achieved with radiotherapy alone for patients with locoregionally advanced undifferentiated or poorly differentiated nasopharyngeal carcinoma (NPC) meeting one of the following criteria: Ho's T3 disease, Ho's N2-N3 disease, or lymph node size > or =3 cm. METHODS: Between September 1989 and August 1993, 334 patients were enrolled in the study, with equal numbers of patients randomized to the neoadjuvant chemotherapy arm (CT arm) and the radiotherapy arm (RT arm). Neoadjuvant chemotherapy consisting of 2-3 cycles of cisplatin (60 mg/m2 on Day 1) and epirubicin (110 mg/m2 on Day 1) followed by radiotherapy was given to the CT arm. For radiotherapy, a dose of 66-74 gray (Gy) (median, 71 Gy) was delivered to the primary tumor and 60-76 Gy (median, 66 Gy) to the neck. Two hundred eighty-six eligible patients completed the treatment and were evaluable for treatment response (134 in the CT arm, 152 in the RT arm). All patients were included in the survival analysis based on the intention to treat. The median follow-up was 30 months for the whole cohort and 41 months for the surviving patients. RESULTS: Analysis of the 334 patients based on the intention to treat showed no significant difference in relapse free survival (RFS) or overall survival (OS) between the 2 treatment arms (3-year RFS rate: 48% in the CT arm vs. 42% in the RT arm, P = 0.45; 3-year OS rate: 78% vs. 71%, P = 0.57). In an efficacy analysis based on only the 286 evaluable patients, a trend of improved RFS favoring the CT arm was observed (3-year RFS rate: 58% vs. 46%, P = 0.053), with again no significant difference in OS (3-year OS rate: 80% vs. 72%, P = 0.21). In the subgroup of 49 patients with bulky neck lymph nodes >6 cm, improved RFS (3-year RFS rate: 63% vs. 28%, P = 0.026) and OS (3-year OS rate: 73% vs. 37%, P = 0.057) were observed, favoring the CT arm. CONCLUSIONS: This multicenter randomized study did not demonstrate any benefit with the addition of cisplatin-epirubicin neoadjuvant chemotherapy for patients with locoregionally advanced nasopharyngeal carcinoma; therefore routine administration of neoadjuvant chemotherapy to this target group cannot be recommended. Although the overall incidence of recurrence was reduced with the addition of chemotherapy in the efficacy analysis, the overall survival was not affected. A more effective chemotherapy regimen, the selection of an appropriate target group, and the use of an alternative strategy for combining chemoradiotherapy should be explored in future trials. 相似文献
196.
Our objective was to determine whether methotrexate is an effective steroid-sparing agent for patients with severe asthma. Published reports of controlled trials assessing the use of methotrexate in asthma were identified by a search of the MEDLINE, EMBASE, CINAHL, Biological Abstracts on CD, and Current Contents databases. Bibliographies from identified studies and from review articles were manually searched. Published and unpublished reports in any language were identified and assessed for inclusion in the meta-analysis. We selected randomized, double-blind, placebo-controlled trials in which low-dose methotrexate was administered to corticosteroid-dependent asthmatics, and oral steroids were subsequently tapered according to the patients' clinical status. Data were extracted independently by two reviewers. For all eligible trials, the mean reduction in oral corticosteroid dose, the mean change in FEV1, and the standard deviations, were calculated for the treatment and control groups. Data concerning side-effects of therapy were also extracted. Data from 12 studies, reporting on a total of 250 patients, were pooled using a weighted average method, with weights proportional to the inverse of the variance of the treatment effect. Compared to placebo, the use of methotrexate was associated with a pooled 6.0% improvement in FEV1 (95% CI, 1.0-11%) and an 18.2% reduction in oral steroid use (95% CI, 11.7-24.7%). This corresponded to a 3.3 mg day-1 greater reduction in oral steroid use for patients taking methotrexate than for those taking placebo (95% CI, 2.1-4.4 mg day-1). Gastrointestinal complications and transient increases in liver enzymes were more common in patients randomized to methotrexate. Three potentially life-threatening side-effects (two pneumonias and one liver dysfunction) occurred in 159 patients randomized to methotrexate vs. none in those patients on placebo. It was concluded that methotrexate allowed a modest reduction in oral corticosteroid compared to patients receiving placebo. The benefit is relatively small, however, and should be balanced against the potential for side-effects associated with the use of methotrexate. 相似文献
197.
198.
Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States 总被引:3,自引:0,他引:3
RC Lawrence CG Helmick FC Arnett RA Deyo DT Felson EH Giannini SP Heyse R Hirsch MC Hochberg GG Hunder MH Liang SR Pillemer VD Steen F Wolfe 《Canadian Metallurgical Quarterly》1998,41(5):778-799
OBJECTIVE: To provide a single source for the best available estimates of the national prevalence of arthritis in general and of selected musculoskeletal disorders (osteoarthritis, rheumatoid arthritis, juvenile rheumatoid arthritis, the spondylarthropathies, systemic lupus erythematosus, scleroderma, polymyalgia rheumatica/giant cell arteritis, gout, fibromyalgia, and low back pain). METHODS: The National Arthritis Data Workgroup reviewed data from available surveys, such as the National Health and Nutrition Examination Survey series. For overall national estimates, we used surveys based on representative samples. Because data based on national population samples are unavailable for most specific musculoskeletal conditions, we derived data from various smaller survey samples from defined populations. Prevalence estimates from these surveys were linked to 1990 US Bureau of the Census population data to calculate national estimates. We also estimated the expected frequency of arthritis in the year 2020. RESULTS: Current national estimates are provided, with important caveats regarding their interpretation, for self-reported arthritis and selected conditions. An estimated 15% (40 million) of Americans had some form of arthritis in 1995. By the year 2020, an estimated 18.2% (59.4 million) will be affected. CONCLUSION: Given the limitations of the data on which they are based, this report provides the best available prevalence estimates for arthritis and other rheumatic conditions overall, and for selected musculoskeletal disorders, in the US population. 相似文献
199.
Prediction Models for Debonding Failure Loads of Carbon Fiber Reinforced Polymer Retrofitted Reinforced Concrete Beams 总被引:1,自引:0,他引:1
This study focuses on debonding failure in reinforced concrete beams with carbon fiber reinforced polymer composite bonded on the soffit using the wet lay-up method. An experimental study, which involved 26 tests, was carried out. The experiments showed two failure modes: Intermediate span debond and end debond. The first failure is the result of the high bond stress near the tip of a flexure-shear crack, whereas the second type of failure is due to the high shear stress developed in the weakest concrete layer at the tension reinforcement level. The experiments have shown that U-straps can be effective in preventing intermediate span and end debond. Based on experimental observations, two simple and practical theoretical models were developed and verified with the experimental data, together with a large database of other existing tests. 相似文献
200.
E Sbarouni ZS Kyriakides A Antoniadis DT Kremastinos 《Canadian Metallurgical Quarterly》1997,80(4):532-535
The hemodynamic effects of estrogens in replacement doses have not been fully clarified; therefore, we studied the acute hemodynamic changes after 0.625 and 1.25 mg of conjugated estrogens, administered intravenously, using a thermodilution catheter, in postmenopausal women without structural heart disease. Pulmonary and systemic pressures and resistances and stroke volume did not change compared with baseline, but heart rate and cardiac output decreased significantly, which may be associated with estrogen's previously described calcium-blocking effect or with a more recently contemplated beta-blocking action. 相似文献